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Abstract
Background: Patient-reported outcomes are measured in many epidemiologic studies using self- or interviewer-
administered questionnaires. While in some studies differences between these administration formats were
observed, other studies did not show statistically significant differences important to patients. Since the
evidence about the effect of administration format is inconsistent and mainly available from cross-sectional
studies our aim was to assess the effects of different administration formats on repeated measurements of
patient-reported outcomes in participants with AIDS enrolled in the Longitudinal Study of Ocular Complications
of AIDS.
Methods: We included participants enrolled in the Longitudinal Study of Ocular Complications in AIDS (LSOCA)
who completed the Medical Outcome Study [MOS] -HIV questionnaire, the EuroQol, the Feeling Thermometer and
the Visual Function Questionnaire (VFQ) 25 every six months thereafter using self- or interviewer-administration. A
large print questionnaire was available for participants with visual impairment. Considering all measurements over
time and adjusting for patient and study site characteristics we used linear models to compare HRQL scores (all
scores from 0-100) between administration formats. We defined adjusted differences of ≥0.2 standard deviations
[SD]) to be quantitatively meaningful.
Results: We included 2,261 participants (80.6% males) with a median of 43.1 years of age at enrolment who
provided data on 23,420 study visits. The self-administered MOS-HIV, Feeling Thermometer and EuroQol were
used in 70% of all visits and the VFQ-25 in 80%. For eight domains of the MOS-HIV differences between the
interviewer- and self- administered format were < 0.1 SD. Differences in scores were highest for the social and
role function domains but the adjusted differences were still < 0.2 SD. There was no quantitatively meaningful
difference between administration formats for EuroQol, Feeling Thermometer and VFQ-25 domain scores. For
ocular pain (VFQ-25), we found a statistically significant difference of 3.5 (95% CI 0.2, 6.8), which did, however,
not exceed 0.2 SD. For all instruments scores were similar for the large and standard print formats with all
adjusted differences < 0.2 SD.
Conclusions: Our large study provides evidence that administration formats do not have a meaningful effect on
repeated measurements of patient-reported outcomes. As a consequence, longitudinal studies may not need to
consider the effect of different administration formats in their analyses.
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Patient-reported outcomes (PRO) are measured in stu-
dies using information that is provided directly by study
participants. Probably most commonly, PROs are used
as outcome measures in epidemiologic studies and clini-
cal trials [1-5]. But PROs also contribute importantly to
the study participants’ profile and are often associated
with future health outcomes. For example, health-related
quality of life (HRQL) or symptoms such as dyspnea can
be strong prognostic indicators [6-8].
PRO instruments are either completed by study parti-
cipants’ themselves (self-administered) or administered
by an interviewer. Self-administered PRO questionnaires
offer the advantage of not requiring research staff as
interviewers and participants to complete the question-
naire at their own pace. It may be offered as a paper-
and pencil method both at the study site or at home
(mail) or through web-based applications. Interviewer-
administered PRO questionnaires are more resource
intensive but offer additional control over the quality of
the measurement. Interviewers may administer the ques-
tionnaires face-to-face or over the telephone. In many
epidemiologic studies, both self- and interviewer-admi-
nistered questionnaires are available to accommodate
preferences, physical impairment or literacy of partici-
pants [9,10].
In a study, the format of questionnaire administration
often varies between participants but it may also vary
within participants from one follow-up to another. The
evidence on the effects of different administration for-
mats on PRO scores is inconsistent. A number of stu-
dies (randomized trials or observational studies) found
that the administration format had an effect on PRO
scores for some or all of the domains [9,11-19]. In some
studies scores indicated less health impairment when
PRO instruments were administered by an interviewer.
A common interpretation of this phenomenon, which is
not entirely understood, is that participants may indicate
less impairment when interviewed by research staff as
compared to self-administered questionnaires. Some
refer to this phenomenon as a social desirability bias
[20]. Other studies did not find meaningful differences
between administration formats [10,21-23]. If effects of
different administration formats exist in epidemiological
studies or clinical trials estimates of associations or
treatment effects may be affected.
Most studies comparing different administration for-
mats were relatively small and considered only one or
two measurements [9,11-19]. The results of these stu-
dies are inconsistent and it is uncertain whether such
unwarranted effects detectedi ns o m em e t h o d o l o g i c a l
studies are also present in a particular epidemiologic
study where PRO instruments are administered
repeatedly over time. Therefore, our aim was to assess
the effects of different administration formats on
repeated measurements of patient-reported outcomes
in a large cohort of persons with AIDS that completed
PRO instruments repeatedly over a long period of
time.
Methods
Study design and participants
We included all participants enrolled in the Longitudi-
nal Study of Ocular Complications of AIDS (LSOCA).
Enrollment started in September 1998 and the data
included here were collected through December 31
st
2009. LSOCA is one of the largest prospective observa-
tional studies of persons with AIDS. Study participants
have AIDS diagnoses according to the 1993 Centers for
Disease Control and Prevention case surveillance defini-
tion of AIDS. Over the course of the study, recruitment
has been performed at 19 clinical centers across the
United States, located in urban areas with sizable HIV-
infected populations. The current number of active
study sites is 13 [24,25]. In this analysis, we included
participants with both incident and prevalent AIDS at
the time of enrollment.
The study protocol was reviewed and approved by
institutional review boards at each of the participating
clinics and the coordinating center. Adult participants
have given written informed consent. For adolescents, a
Consent Statement was signed by parents or guardians
and an Assent Statement signed by adolescents and
their parents or guardians. More detailed information
about the study protocol, data forms and the study
handbook is available on http://www.lsoca.com.
PRO instruments
At enrollment and every six months thereafter, study
participants completed the Medical Outcome Study
(MOS)-HIV Health Survey, the EuroQol, the Feeling
Thermometer and the Visual Function Questionnaire 25
(VFQ-25). Between 1998 and 2008, the subset of partici-
pants with major ocular complications (ocular opportu-
nistic infections and major retinal vessel occlusions) had
study visits every three months where they completed
the questionnaires. The MOS-HIV has 35 items and
scores range from 0 (lowest score) to 100 (highest
score) [26,27]. Its development was based on the Short-
Form 20 of the Medical Outcomes Study and HIV/
AIDS-specific domains were added (energy, cognitive
functioning, health distress, health transition and quality
of life) to the existing domains (general health percep-
tions, physical function, role function, role function,
social functioning, pain and mental health). One item
was added to the pain domain. The MOS-HIV has been
used extensively in clinical trials and cohorts studies of
patients with HIV/AIDS.
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depression, mobility, usual activities, pain/discomfort
and self-care [28]. Different combinations of responses
(on a 5-point Likert-type scale) for the five dimensions
are weighted using preferences identified by the US gen-
eral population [29] The lowest possible score is -0.594
and the highest is 100. The Feeling Thermometer com-
plements the five questions of the EuroQol and asks
participants to rate their health status from 0 (equivalent
to the worst imaginable health state) to 100 (equivalent
to the best imaginable health state). The Feeling Ther-
mometer has been shown to be a reliable, valid and
responsive utility measure for various diseases.
The National Eye Institute VFQ-25 was developed to
measure vision-specific HRQL in patients with varying
eye conditions such as cataract, glaucoma, diabetic reti-
nopathy, cytomegalic virus retinitis and corneal diseases
[30,31]. The VFQ-25 measures the influence of visual
ability and visual symptoms on health domains and on
task-oriented domains. There are domain scores for
social functioning, role limitations, dependency on
others, mental health, future expectations on vision,
near vision activities, distance vision activities, driving
difficulties, pain and discomfort in or around the eyes,
limitations with peripheral vision and color vision. The
VFQ-25 provides reliable and valid scores that are
responsive to change. Scores range from 0 (lowest
score) to 100 (highest score). In LSOCA, the VFQ-25
was introduced in September 2008.
Administration formats
The most common format used to complete the HRQL
instruments in LSOCA is the self-administered format.
This means that participants complete the question-
naires themselves using paper and pencil. Reasons to
switch to interviewer-administered questionnaires
include inability to read because of sight limitations,
dilated pupils for eye examination, illiteracy or for logis-
tical reasons to save time. Thus the choice of adminis-
tration format depends on characteristics of participants
and the study site. The wording and layout of self- and
interviewer-administered questionnaires was identical.
In addition, a large print version for all questionnaires
was added in May 2008. Participants can complete the
large print version if they desire. The font size of the
large print version is 14 points compared to 10 points
in the standard version. The reasons to switch to a large
print format usually relate to the participant’sv i s u a l
impairment or failure to bring reading glasses to a visit.
The choice of administration format is made at every
visit. Theoretically, the administration format may
change from visit to visit although this is rarely the case.
The questionnaire administration format is recorded for
every visit. For the current analyses, only data from in-
person visits were included whereas data from telephone
interviews were not considered.
Statistical analysis
We first determined the number and proportion of inter-
viewer- versus self-administered and large-versus
small-print questionnaires, respectively, at baseline and
follow-up visits and assessed how these numbers changed
as a function of time from enrollment. We also deter-
mined the number of participants who switched from the
standard self- to an interviewer-administered question-
naire. We calculated mean scores for all HRQL domains
stratified by administration ("Proc Univariate” command).
We then compared the HRQL scores between administra-
tion formats (interviewer- versus self-administered and
large- versus small-print) to assess whether they differed,
which we defined as ≥0.2 standard deviations from the
baseline assessment. The standard deviations for the dif-
ferent instruments and their domains at baseline as well as
our thresholds for a quantitatively meaningful difference
are shown in Table 1. For each patient, we considered all
measurements and administration formats used over time
and employed linear regression models ("regress” com-
mand of Stata) while accounting for within subject corre-
lation ("cluster” option) and calculating robust standard
errors using the Huber-White sandwich estimators
("robust” option). Since the choice of administration for-
mat is not random as explained above, patient and study
site characteristics are likely to be associated with differ-
ences between HRQL scores of different administration
formats. Therefore, we adjusted the comparison for study
site and the participants’ sex and for the time-varying vari-
ables age, CD4+ T cells, HIV viral load and visual acuity.
We also checked for the potential influence of sex, age
and disease severity (CD4+ T cell count) on the effect of
administration format and included interaction terms into
the regression models to test for effect modification. In a
sensitivity analysis, we assessed a cross-sectional sample of
participants who switched administration formats from
self to interview for the first time. We compared the differ-
ences in their mean scores on the two administration for-
mats using the Wilcoxon signed rank test We used SAS
(version 9.2, SAS Institute, Cary, NC) for data manage-
ment and for computing descriptive statistics and Stata for
the regression analyses (version 10.1, Stata Corp; College
Station, TX).
Results
We included 2,261 participants in the analysis. The
patient population was predominantly male (81%) with a
median age of 43 years (interquartile range [IQR] 38-
49), of non-hispanic white (46%) or black ethnicity
(36%). At enrollment, 409 participants (18%) had been
diagnosed with AIDS for one year or less (incident
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year. Median CD4+ T cell count at enrollment was 174
cells/μL (IQR 61-339), median nadir CD4+ T cell count
was 31 cells/μL (IQR 10-91) and median HIV RNA
(viral load) level was 2.9 (log10[copies/mL], IQR 1.9-4.7).
Overall, 83.0% of participants received HAART at
enrollment.
Administration formats
The majority of visits involved self-administered PRO
questionnaires (70% of a total of 23,420 study visits). Of
the 2,261 patients, 929 (41%) completed their first (base-
line) questionnaires via interview and 1,332 (59%) com-
pleted it via self-administration. In 6,910 (30%) visits the
HRQL questionnaires were interviewer-administered
and in 224 (1%) visits participants used the self-adminis-
tered version with large print letters. These percentages
changed with follow-up (Figure 1). The percentages of
self-administered questionnaires (standard and large
print formats) increased from 63% in the first year of
enrollment to 77% beyond five years of enrollment. Of a
total of 2,336 visits where the VFQ-25 was completed,
participants used the self-administered format in 1,878
(80%) visits (standard print in 1,708 [91%] visits and
large print in 170 [9%] visits) and had it interviewer-
administered in 458 (20%) visits.
Out of the 2,261 participants, 1,730 (77%) started
with the self-administered MOS-HIV, EuroQol and
Feeling Thermometer whereas 531 participants (23%)
started with the interviewer-administered format. 1,265
(56%) never switched the administration format of the
MOS-HIV, EuroQol and Feeling Thermometer, 335
(15%) switched permanently and 661 (29%) switched
intermittently. Of the 1,096 participants who com-
pleted the VFQ-25 989 (90%) never switched adminis-
tration format, 93 (9%) switched permanently and 14
(1%) switched intermittently.
Interviewer- versus self-administered questionnaires
For eight domains of the MOS-HIV, we did not find sta-
tistically significant differences between the interviewer-
and self- administered formats (Table 2). For the general
health perceptions, role function and social function
domains, scores were higher for the self- administered
format but adjusted differences were < 0.2 SD. The differ-
ence between self- and interviewer-administered ques-
tionnaires was statistically significant for the Feeling
Thermometer but also < 0.2 SD. For the VFQ-25, there
Table 1 Standard deviations for generic and vision specific health-related quality of life scores as obtained from
baseline assessment of 2,261 participants enrolled in the Longitudinal Study of Ocular Complications in AIDS (LSOCA)
Generic instruments Vision-specific instruments
Instrument and
domain
Standard
deviation
0.2 of pooled standard deviation
(defined here as meaningful
difference)
Instrument
and domain
Standard
deviation
0.2 of pooled standard deviation
(defined here as meaningful
difference)
Self Interview Self Interview
MOS-HIV VFQ-25
General
health
21.7 23.2 4.5 Composite
score
14.0 17.6 3.0
Physical
function
26.8 27.9 5.4 General vision 16.0 21.1 3.4
Role
function
45.0 45.0 9.0 Ocular pain 18.5 18.3 3.7
Social
function
28.6 31.8 6.0 Near activities 19.2 22.2 4.0
Cognitive
function
24.2 25.1 4.9 Distance
activities
16.6 19.7 3.5
Pain 27.0 28.3 5.5 Social
functioning
14.3 17.9 3.0
Mental
health
14.7 16.2 3.1 Mental health 19.4 21.5 4.0
Energy 22.1 24.8 4.6 Role difficulties 24.9 26.7 5.1
Quality of
life
21.0 22.9 4.4 Dependency 18.1 20.9 3.7
Health
transitions
23.8 24.4 4.8 Driving 20.9 31.5 4.7
Health utility Color vision 12.9 17.4 2.8
Feeling
thermometer
19.2 21.0 4.0 Peripheral
vision
21.3 24.2 4.4
EQ-5D 0.17 0.19 0.036
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20
40
60
80
1 2 3 4 5 6 or more
Years since enrollment
Percentage of 
visits
Self-administration with 
standard print
Self-administration with 
large print
Interviewer-administration
with standard print
Number of visits
Self-administration with 
standard print
3,431 2,333 2,094 1,886 1,605 4,937
Self-administration with 
large print
9 18 7 20 18 152
Interviewer-administration 
with standard print
2,054 1,097 910 754 593 1,502
16,286 (69.5%)
224 (1.0%)
6.910 (29.5%)
Total
Figure 1 Study participants and administration formats. The graph shows the percentage of study participants and the different
administration formats they chose since time of enrolment. All study visits (n = 23,420) of all participants (n = 2,261) contributed to the analyses.
The percentage of self administration with the standard print increased from 62% in the first year of enrolment to 75% if participants were
enrolled six years or more. Interviewer administration with standard print decreased from 37% to 23% and self administration with large print
increased from 1% to 2%.
Table 2 Generic health-related quality of life scores: Interviewer- versus Self-administration and Large- versus Small
print
Health-related quality of
life domain
Interviewer- versus Self-administration Large versus Standard print format
Total
(23,420
visits)
Interview
(6,910
visits)
Self
(16,510
visits)
Adjusted difference*
(95% CI)
Large (224
visits)
Standard
(16,286
visits)
Adjusted difference*
(95% CI)
MOS-HIV Health Survey
General health perceptions,
mean
63.9 62.1 64.7 -1.7 (-3.2, -0.1), p = 0.03 65.5 64.7 -0.2 (-3.6, 3.2), p = 0.9
Physical function 71.2 69.4 72.0 -1.6 (-3.4, 0.3), p = 0.1 68.0 72.0 -3.3 (-7.4, 0.9), p = 0.1
Role function 52.1 46.7 54.4 -6.8 (-9.9, -3.7),
p < 0.001
54.7 54.4 -2.6 (-9.5, 4.3), p = 0.5
Social function 74.9 72.2 76.1 -3.9 (-5.8, -2.1),
p < 0.001
72.9 76.1 -0.6 (-5.0, 3.8), p = 0.8
Cognitive function 76.6 77.0 76.4 -1.1 (-2.6, 0.4), p = 0.2 75.0 76.4 -0.2 (-3.7, 3.4), p = 0.9
Pain 67.0 66.6 67.2 0.5 (-1.3, 2.4), p = 0.6 62.4 67.3 -3.4 (-7.5, 0.7), p = 0.1
Mental health 43.3 43.8 43.2 0.0 (-0.9, 1.0), p = 0.9 44.0 43.2 0.8 (-1.6, 3.3), p = 0.5
Energy 56.4 54.6 57.2 -0.7 (-2.4, 1.0), p = 0.4 54.6 57.2 -2.8 (-6.6, 1.0), p = 0.2
Quality of life 66.3 65.1 66.8 -0.5 (-1.9, 1.0), p = 0.5 65.7 66.8 -3.1 (-6.6, 0.5), p = 0.09
Health transition 59.8 59.1 60.1 -0.2 (-1.5, 1.2), p = 0.8 59.8 60.1 -1.2 (-4.7, 2.3), p = 0.5
Health utility
Feeling Thermometer 73.8 72.7 74.2 -1.4 (-2.7, -0.1), p = 0.03 75.3 74.2 1.4 (-1.5, 4.3), p = 0.3
EuroQol - 5D 0.80 0.79 0.80 -0.01 (-0.02, 0.01),
p = 0.3
0.78 0.80 -0.02 (-0.05, 0.01),
p = 0.1
* Adjusted for study site, sex, current age, and time-varying covariates CD4+ T cells, HIV viral load, and visual acuity.
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twelve domains (Table 3). For ocular pain, we found a
significant difference of 3.5 (95% CI 0.2, 6.8) but this dif-
ference was below the threshold of 0.2 SD that we
defined to be quantitatively meaningful. Unadjusted
results were similar to adjusted results for the MOS-HIV,
Feeling Thermometer and EuroQol with all differences
between administration formats < 0.2 SD. For the VFQ-
25, we found differences ≥0.2 SD for six out of twelve
domains. We did not find any evidence for an interaction
of sex, age and disease severity (CD4+ T cell count) with
administration format (none of the interaction terms
with p ≤ 0.05).
465 participants who started with self-administration
and switched at least once to interviewer-administered
questionnaires were available for the sensitivity analysis.
We did not find any statistically significant differences
between scores of the MOS-HIV, Feeling Thermometer,
EuroQol and VFQ-25 from the last study visit before
the switch (self-administered) to scores obtained at the
first visit where interviewer administration was chosen.
All differences were below the thresholds for a meaning-
ful difference.
Large- versus standard print format
For all domains of the MOS-HIV, the Feeling Thermo-
meter and EuroQol the scores were similar for the large
and standard print formats and we did not find statistically
significant differences (Tables 2 and 3). All differences
were below 0.2 SD. Also, we did not find any significant
differences for the VFQ-25. Unadjusted differences were
also all < 0.2 SD.
Discussion
In our analysis of more than 23,000 clinic visits of parti-
cipants with AIDS, different administration formats of
generic or disease-specific PRO instruments did not
have a meaningful effect on HRQL scores measured
repeatedly over time. Differences between all scores of
the interviewer- and self-administered questionnaires
were below our predefined threshold for a quantitatively
meaningful difference. Also, the use of the large print
format did not have an impact on HRQL scores.
We defined a meaningful difference between adminis-
tration formats to be ≥0.2 SD, which corresponds to a
small but potentially important difference as first
defined by Cohen [32]. Other studies used similar cri-
teria for defining a threshold for meaningful differences
between PRO scores [9]. Adjusted differences were all
below 0.2 SD, but it should be noted that the estimates
were precise for the comparison of the interviewer- and
self-administered HIV-MOS with confidence intervals
that were mostly within ± 0.2 SD. In contrast, since the
VFQ-25 and the large print format were introduced
more recently, sample size was considerably smaller for
these comparisons and some 95% confidence intervals
overlapped ± 0.2 SD. Hence, although mean differences
were small for most comparisons of the VFQ-25 and
Table 3 Vision-related health-related quality of life scores: Interviewer- versus Self-administration and Large- versus
Small print
Health-related quality of life
domain
Interviewer- versus Self-administration Large versus Standard print format
Total
(2,336
visits)
Interview
(458
visits)
Self
(1,878
visits)
Adjusted difference*
(95% CI)
Large
(170
visits)
Standard
(1,708
visits)
Adjusted difference*
(95% CI)
Visual Functioning
Questionnaire
Composite visual functioning,
mean
86.5 83.9 87.2 -0.1 (-2.6, 2.5), p = 0.9 87.4 87.1 2.1 (-1.1, 5.2), p = 0.2
General vision 76.7 73.2 77.6 -1.8 (-4.6, 1.0), p = 0.2 78.1 77.5 2.2 (-1.6, 6.1), p = 0.3
Ocular pain 86.4 87.6 86.1 3.5 (0.2, 6.8), p = 0.04 86.9 86.0 2.3 (-2.0, 6.6), p = 0.3
Near activities 83.1 81.5 83.5 1.2 (-2.3, 4.7), p = 0.5 82.6 83.6 2.9 (-1.5, 7.4), p = 0.2
Distance activities 88.2 86.1 88.8 0.7 (-2.3, 3.6), p = 0.7 88.0 88.8 2.3 (-1.8, 6.5), p = 0.3
Vision specific
Social functioning 93.5 90.3 94.3 -0.7 (-3.2, 1.7), p = 0.6 93.5 94.4 0.9 (-2.8, 4.5), p = 0.6
Mental health 84.0 80.8 84.7 -0.4 (-4.1, 3.3), p = 0.8 86.9 84.5 2.7 (-1.7, 7.0), p = 0.2
Role difficulties 83.4 80.2 84.2 -2.6 (-7.3, 2.1), p = 0.3 84.0 84.2 0.9 (-4.6, 6.3), p = 0.8
Dependency 91.1 87.0 92.1 -1.9 (-5.3, 1.4), p = 0.3 93.4 91.9 2.9 (-1.0, 6.8), p = 0.1
Driving 82.6 76.9 83.9 0.2 (-4.2, 4.7), p = 0.9 84.9 83.7 1.6 (-3.2, 6.4), p = 0.5
Color vision 95.2 92.5 95.9 -0.3 (-2.6, 2.0), p = 0.8 95.9 95.9 0.6 (-2.8, 4.0), p = 0.7
Peripheral vision 87.1 84.6 87.7 1.2 (-2.7, 5.0), p = 0.6 87.6 87.7 3.4 (-2.4, 9.2), p = 0.2
* Adjusted for study site, sex, current age, and time-varying covariates CD4+ T cells, HIV viral load, and visual acuity.
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scores measured by interviewer- and self-administered
questionnaires. We did not calculate sample size
requirements for our study. But if a randomized trial
was planned to compare administration formats and the
“General Health” domain of the HIV-MOS was the out-
come of interest, 526 patients would be needed per trial
arm to detect a difference of at least 0.2 SD (4.5 points,
assuming a pooled SD of 22.5 points) and a standard 5%
chance of two-sided type I (false positive) error and 90%
power. Our study sample far exceeded that sample size.
The results of studies comparing different administra-
tion formats, including ours, are heterogeneous. Some
studies found scores indicating less impairment with
interviewer- than with self-administered questionnaires
[9,11-19], which was more pronounced for mental
health domains in some studies [9,13]. In other studies,
investigators did not observe such differences [10,21-23].
To our knowledge, our analysis is the only one embed-
ding the comparison of administration formats in a
large cohort study with repeated measurements over
time. This allows us to estimate differences between
administration formats with greater precision, in a
cohort study setting and to do a sensitivity analysis that
compared PRO scores within participants. A possible
explanation for the absence of differences between
administration formats could be that a social desirability
bias, that is commonly proposed to explain why inter-
viewer administration leads to higher scores [20], may
wash out over time. It seems unlikely, that participants,
who come repeatedly for study visits, would consistently
overestimate their health. In most studies that compared
administration formats, there was only one (cross-sec-
tional) administration where patients are likely to be
unfamiliar with the study or clinic setting and where a
s o c i a ld e s i r a b i l i t yb i a sm a yb em o r el i k e l yt ob ep r e s e n t
than in a study with follow-up. However, the hypothesis
that the social desirability bias washes out over time
would require further testing in a randomized trial com-
paring administration formats where repeated measure-
ments are available.
If an effect of administration format is present investi-
gators should be concerned with a potential effect that
may alter inferences in two ways. First, different admin-
istration formats may introduce additional measurement
variability, which makes the detection of small but
important associations or effects more difficult. Sample
size requirements to detect a certain difference in PRO
could be larger if different administration formats are
used because of greater standard deviations and because
effect estimates are likely to be attenuated by additional
(non-differential) measurement error [9,10]. Second, if
different administration formats influence scores, effect
estimates could be affected.
For example, one could be interested in comparing
HRQL between HIV-infected persons with and without
AIDS (Figure 2). Let us assume that HRQL is measured
by a HRQL instruments with scores from 0 to 100. In
the absence of effects from administration format (sce-
nario 1 in Figure 2), we could, for example, expect a
mean score of 50 for persons with AIDS and of 70 for
HIV-infected persons without AIDS resulting in a mean
difference of 20 units. If interviewer-administered ques-
tionnaires are offered it can be expected that more per-
sons with AIDS will choose this format (for example
30%) because they have, on average, more visual (for
example because of cytomegalovirus retinitis) and more
cognitive impairment (for example because of brain tox-
oplasmosis) than HIV-infected persons without AIDS
(scenarios 2 and 3 in Figure 2). If interviewer-adminis-
tered questionnaires lead to different scores compared
to self-administered questionnaires the difference in
HRQL between AIDS and non-AIDS persons would be
affected.
We see two solutions to address this issue. One solu-
tion would be to restrict the administration format
strictly to one mode of administration. Since this may
be unrealistic in many studies a second solution would
be to record the administration format at each study vis-
its and check for an independent effect of administra-
tion format on PRO scores as we did in this study.
Intuitively, investigators may think that one should
adjust the effect estimate for administration format,
which has also been proposed in the literature [9]. How-
ever, the causal diagram in Figure 2 shows that adminis-
tration format does not act as a confounder since it is
affected by AIDS status, but as an intermediate. In fact,
adjusting for administration format would attenuate or
increase the association of AIDS status and HRQL and
lead to potential under- or over-estimation. Instead, we
propose that the effect caused by administration format
in some studies should be corrected by the use of meth-
ods to account for measurement error such as regres-
sion calibration or multiple imputation [33-35]. The
idea of regression calibration is to correct the observed
value, which is known or suspected not to represent the
true value, using information from repeated measure-
ments or from substudies that yield the true values for
some patients (e.g. by sing a reference standard mea-
surement method or some instrumental variable). With
the multiple imputation approach, the true values are
regarded to be missing and can be imputed using infor-
mation similar to the information used in the regression
calibration approach (repeated measurements or true
values from substudy). We would like to point out
though that we would not consider the effect of admin-
istration format to be a measurement error and its effect
on estimation an information bias (bias in effect
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Page 7 of 11estimation caused by measurement error) since neither
of the different methods of measurement are superior
and since no reference standard for PRO exists.
Strengths of our analysis include the large sample
size and the repeated administrations of PRO instru-
ments over time. Thereby, our analysis represents the
typical cohort study settings for which there is little
evidence on the effects of administration formats and
we have little reason to assume that the results of our
study are specific to patients with AIDS only. Another
strength is the adjustment for patient and study site
characteristics that could have confounded the com-
parisons. However, a limitation of our study is the lack
of randomization for administration format so that
some residual confounding might still be present. Also,
since the VFQ-25 and the large print format were
introduced rather recently the sample size was smaller
for investigating the effects of administration format
on VFQ-25 scores or of the large versus standard
print.
Our large study provides evidence that administration
formats do not have a meaningful effect on repeated
measurements of PRO. As a consequence, longitudinal
studies may not need to consider different administra-
tion formats in their analyses. However, if investigators
find an effect of administration format they should not
adjust for the administration format but consider using
one of the methods available for correcting systematic
measurement error.
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